Author:
Garibyan Anna,Delyagina Ekaterina,Agafonov Mikhail,Khodov Ilya,Terekhova Irina
Funder
Russian Science Foundation
Subject
Materials Chemistry,Physical and Theoretical Chemistry,Spectroscopy,Condensed Matter Physics,Atomic and Molecular Physics, and Optics,Electronic, Optical and Magnetic Materials
Reference34 articles.
1. Olumiant product information, European public assessment report. European Medicines Agency. https://www.ema.europa.eu/en/medicines/human/EPAR/olumiant#authorisation-details-section.
2. Prediction of Transporter-Mediated Drug-Drug Interactions for Baricitinib;Posada;Clinical and Translational Science,2017
3. JAK-STAT inhibitors for the treatment of immunomediated diseases;Serra López-Matencio;Medicina Clínica (English Edition),2019
4. Effect of Baricitinib on TPA-induced psoriasis like skin inflammation;Hiraganahalli Bhaskarmurthy;Life Sciences 279,2021
5. Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study;King;Journal of the American Academy of Dermatology,2021
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献